BioCorRx Inc.
BICX
$0.34
$0.013.03%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 531.25% | 10,389.47% | 3,478.49% | 755.46% | 166.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 531.25% | 10,389.47% | 3,478.49% | 755.46% | 166.09% |
| Cost of Revenue | -- | 1,182.35% | 2,324.32% | -100.00% | -100.00% |
| Gross Profit | 497.48% | 12,823.33% | 4,853.78% | 1,620.33% | 491.06% |
| SG&A Expenses | -1.73% | 5.03% | 18.09% | 40.46% | 32.49% |
| Depreciation & Amortization | -40.63% | 32.93% | 578.36% | 334.70% | 91.04% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.36% | 9.72% | 31.43% | 31.01% | 39.39% |
| Operating Income | 4.88% | 5.68% | -12.48% | -24.58% | -37.61% |
| Income Before Tax | 27.13% | 32.68% | 13.90% | -15.37% | -20.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 27.13% | 32.68% | 13.90% | -15.37% | -20.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -24.81% | -35.19% | -2,150.80% | 1,178.42% | 3,302.94% |
| Net Income | 27.19% | 32.63% | -5.04% | -10.21% | -17.94% |
| EBIT | 4.88% | 5.68% | -12.48% | -24.58% | -37.61% |
| EBITDA | 7.21% | 8.60% | -9.32% | -22.56% | -37.21% |
| EPS Basic | 54.70% | 57.82% | 37.25% | 26.36% | 11.12% |
| Normalized Basic EPS | 52.05% | 57.45% | 32.77% | 33.52% | 16.34% |
| EPS Diluted | 54.70% | 57.82% | 37.25% | 26.36% | 11.31% |
| Normalized Diluted EPS | 52.05% | 57.45% | 32.77% | 33.52% | 16.34% |
| Average Basic Shares Outstanding | 74.37% | 75.67% | 66.86% | 57.53% | 40.13% |
| Average Diluted Shares Outstanding | 74.37% | 75.67% | 66.86% | 57.53% | 40.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |